23
Mar 2026
A free open-access webinar will introduce the Cancer Genome Interpreter (CGI), an advanced bioinformatics tool to interpret mutations in cancer genomes developed by IRB Barcelona and co-created with European hospitals to turn complex cancer genomics into actionable insights.
23
Mar 2026
Applying artificial intelligence techniques to cardiac ultrasound data may make it easier to identify patients with advanced heart failure, a new study has found.
23
Mar 2026
Lena Ting, from Emory University, and colleagues explored how brain and muscle activity during balance recovery change due to aging and Parkinson's.
23
Mar 2026
Nearly three years after the SARS-CoV-2 pandemic was declared over, conservative estimates suggest that between 80 million and 400 million people worldwide have long COVID.
23
Mar 2026
Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global health priority.
23
Mar 2026
Researchers at VCU Massey Comprehensive Cancer Center are leading an international study that advances the understanding of the immunoregulatory nature of human tissues, offering breakthrough insights into how fibroblasts serve as the core regulators of structural immunity in the mouth.
23
Mar 2026
During intensive care after preterm births, babies can experience low oxygen in their tissue and cells-or hypoxia.
23
Mar 2026
Alzheimer's disease is characterised by the accumulation of two proteins in the brain: amyloid-beta and tau.
23
Mar 2026
Neurodegenerative diseases form a tangled biological web with overlapping molecular signatures and symptoms. To decode this complexity, a multi-institute collaboration led by St. Jude Children's Research Hospital scientists developed the pan-neurodegeneration atlas (PanNDA).
23
Mar 2026
A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to patient outcomes using widely available bulk RNA sequencing data.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
